Related Experiment Video
Updated: Jun 22, 2025
13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
10.5K
Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease
Valentin Calvez1, Guia Becherucci1, Carlo Covello1
1CEMAD Digestive Disease Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Catholic University of Rome, 00168 Rome, Italy.
Biomedicines
|June 27, 2024
Summary
Sarcopenia, a loss of muscle mass and strength, is common in inflammatory bowel diseases (IBDs). Management includes exercise, nutrition, and therapies targeting the gut-muscle axis to improve patient outcomes.
Area of Science:
- Gastroenterology and Musculoskeletal Health
Background:
- Inflammatory bowel diseases (IBDs) are systemic conditions with significant gastrointestinal and extraintestinal manifestations.
- Sarcopenia, characterized by reduced muscle mass and strength, is highly prevalent in Crohn's disease (52%) and ulcerative colitis (37%).
Purpose of the Study:
- To provide a comprehensive review of sarcopenia in IBDs, covering diagnostic methods, pathophysiology, clinical implications, and management strategies.
- To explore the emerging concern of sarcopenic obesity in IBDs, including its pathogenesis and treatment.
Main Methods:
- Review of current literature on sarcopenia in IBDs.
- Discussion of diagnostic tools such as ultrasound and grip strength testing.
- Exploration of the 'gut-muscle axis' hypothesis and contributing factors like inflammation and malnutrition.
Main Results:
- Sarcopenia negatively impacts IBD patients, increasing surgical risks, reducing treatment response, and impairing quality of life.
- Resistance exercise, nutritional support (especially protein), and anti-TNF therapies show promise in managing sarcopenia in IBDs.
Conclusions:
- Sarcopenia is a significant complication of IBDs requiring targeted diagnostic and therapeutic approaches.
- Further research into sarcopenic obesity in IBDs is crucial for understanding and managing this complex condition.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
212
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
212
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:17Chronic Bowel Disorders: Introduction
439
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
439
01:21Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
01:29Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125